Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Malignant Lymphoma

  Free Subscription


03.06.2024

3 Blood
6 Br J Haematol
1 Cancer
1 Cancer Lett
2 Haematologica
1 Leuk Lymphoma
1 N Engl J Med
1 PLoS One


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Blood

  1. SMITH MR, Jegede O, Martin P, Till B, et al
    Randomized Bendamustine-Rituximab(R) + Bortezomib Induction and R + Lenalidomide Maintenance for Mantle Cell Lymphoma.
    Blood. 2024 May 31:blood.2024023962. doi: 10.1182/blood.2024023962.
    PubMed         Abstract available

  2. APAYDIN ARIKAN E, Jaffe ES
    Mantle cell lymphoma with marked plasmacytic differentiation: two contrasting faces.
    Blood. 2024;143:2337.
    PubMed        

  3. BRINKMANN BJ, Floerchinger A, Schniederjohann C, Roider T, et al
    CD20-bispecific antibodies improve response to CD19-CAR T-cells in lymphoma in-vitro and CLL in-vivo models.
    Blood. 2024 May 28:blood.2023022682. doi: 10.1182/blood.2023022682.
    PubMed         Abstract available


    Br J Haematol

  4. SHORTT J, Opat S
    Large cell lymphoma through a liquid lens.
    Br J Haematol. 2024 May 30. doi: 10.1111/bjh.19502.
    PubMed         Abstract available

  5. ALCOCEBA M, Stewart JP, Garcia-Alvarez M, Diaz LG, et al
    Liquid biopsy for molecular characterization of diffuse large B-cell lymphoma and early assessment of minimal residual disease.
    Br J Haematol. 2024 May 29. doi: 10.1111/bjh.19458.
    PubMed         Abstract available

  6. STEWART DA, Kuruvilla J, Lee D, Dudebout JJ, et al
    Canadian cancer trials group LY.17: A randomized phase II study evaluating novel salvage therapy pre-autologous stem cell transplant in relapsed/refractory diffuse large B-cell lymphoma-outcome of rituximab-dose-intensive cyclophosphamide, etoposide,
    Br J Haematol. 2024 May 27. doi: 10.1111/bjh.19555.
    PubMed         Abstract available

  7. OTHMAN T, Baird JH, Pak S, Mei M, et al
    Real-world experience of axicabtagene ciloleucel, a CD19-directed CAR T-cell therapy, in the second-line treatment of early relapsed or primary refractory large B-cell lymphoma.
    Br J Haematol. 2024 May 26. doi: 10.1111/bjh.19521.
    PubMed        

  8. EPPERLA N, Hashmi H, Ahn KW, Allbee-Johnson M, et al
    Outcomes of patients with secondary central nervous system lymphoma treated with chimeric antigen receptor T-cell therapy: A CIBMTR analysis.
    Br J Haematol. 2024 May 26. doi: 10.1111/bjh.19569.
    PubMed        

  9. RUPAKUMAR T, Sankar A, Vijayasekharan K, Varikkattu Rajendran P, et al
    Older age, CNS leukaemic involvement and induction tumour lysis increases the risk of methotrexate (MTX)-induced neurotoxicity in childhood acute lymphoblastic leukaemia/lymphoma: Experience from a tertiary care centre in South India.
    Br J Haematol. 2024 May 26. doi: 10.1111/bjh.19559.
    PubMed         Abstract available


    Cancer

  10. LI ZH, Zhang MY, Federico M, Civallero M, et al
    Early histological transformation of follicular lymphoma to diffuse large B-cell lymphoma indicating adverse survival: A population-based analysis and validation.
    Cancer. 2024 May 29. doi: 10.1002/cncr.35378.
    PubMed         Abstract available


    Cancer Lett

  11. HU D, Cao J, Yu H, Ding N, et al
    PI3K inhibitor idelalisib enhances the anti-tumor effects of CDK4/6 inhibitor palbociclib via PLK1 in B-cell lymphoma.
    Cancer Lett. 2024 May 28:216996. doi: 10.1016/j.canlet.2024.216996.
    PubMed         Abstract available


    Haematologica

  12. DANILOV AV, Flinn IW, Davids MS, Gregory B, et al
    The phase III DUO trial of PI3K inhibitor duvelisib versus ofatumumab in relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma: final analysis including overall survival.
    Haematologica. 2024 May 30. doi: 10.3324/haematol.2024.285043.
    PubMed         Abstract available

  13. GHIONE P, Salles G
    Spotlight on polatuzumab vedotin: new standards for diffuse large B-cell lymphoma?
    Haematologica. 2024 May 30. doi: 10.3324/haematol.2022.282362.
    PubMed         Abstract available


    Leuk Lymphoma

  14. LEWIS KL, Cheah CY
    The value of bispecific antibodies in relapsed and refractory DLBCL.
    Leuk Lymphoma. 2024;65:720-735.
    PubMed         Abstract available


    N Engl J Med

  15. CHEN ST, Cochran RL, Jain S, Stagner AM, et al
    Case 15-2024: A 73-Year-Old Woman with Worsening Rash.
    N Engl J Med. 2024;390:1803-1813.
    PubMed        


    PLoS One

  16. ZHANG Q, Li L, Yang H
    Application of fused graphical lasso to statistical inference for multiple sparse precision matrices.
    PLoS One. 2024;19:e0304264.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.